CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing Post author: Post published:December 4, 2023 Post category:uncategorized CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH). You Might Also Like Skin and internal organs sense cold through different molecular pathways December 21, 2025 Bipartisan obesity bill gains support from Endocrine Society June 5, 2025 Brain-body interactions during hunger make imagined food especially tempting June 3, 2026